Lasers Highlight Ketamine's Depression-Fighting Secrets
Apr 12, 2019•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Last month, the FDA approved esketamine, the nose spray version of ketamine, for treatment-resistant depression. You probably know by now that ketamine is a party drug, but it actually finds far wider use as an anesthetic on the World Health Organization’s list of Essential Medicines. Scientists have a good idea of how exactly it brings about its anesthetic charms, on account of it interacting with certain receptors in the brain.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android